Publications (15) Natalia Alonso Vence publications

2022

  1. Erratum: Correction: Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia (PloS one (2021) 16 2 (e0247093))

    PloS one

  2. Erratum: Gene expression profiling identifies FLT3 mutation-like cases in wildtype FLT3 acute myeloid leukemia (PLoS ONE (2021) 16:2 (e0247093) DOI: 10.1371/journal.pone.0247093)

    PLoS ONE

2021

  1. Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes

    PloS one, Vol. 16, Núm. 5, pp. e0248886

  2. Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia

    PloS one, Vol. 16, Núm. 2, pp. e0247093

  3. Personalized Survival Prediction of Patients With Acute Myeloblastic Leukemia Using Gene Expression Profiling

    Frontiers in Oncology, Vol. 11

  4. Survival prediction and treatment optimization of multiple myeloma patients using machine-learning models based on clinical and gene expression data

    Leukemia, Vol. 35, Núm. 10, pp. 2924-2935

2020

  1. FLT3 inhibitors in the treatment of acute myeloid leukemia: Current status and future perspectives

    Minerva Medica, Vol. 111, Núm. 5, pp. 427-442

  2. Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling

    BMC Cancer, Vol. 20, Núm. 1

  3. Novel Mutation Hotspots within Non-Coding Regulatory Regions of the Chronic Lymphocytic Leukemia Genome

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution

    BMC Cancer, Vol. 19, Núm. 1

2010

  1. Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant)

    Annals of Hematology

2009

  1. Identification of leptomeningeal disease in aggressive B-Cell non-Hodgkin's lymphoma: Improved sensitivity of flow cytometry

    Journal of Clinical Oncology, Vol. 27, Núm. 9, pp. 1462-1469

  2. Study of the relation between the time course of the JAK2V617F allele burden and the clinical evolution in patients with myeloproliferative neoplasms; a single center study

    Acta Haematologica Polonica, Vol. 40, Núm. 3, pp. 613-619

2003

  1. Anticoagulación oral

    Anales de medicina interna, Vol. 20, Núm. 7, pp. 377-384

  2. Anticoagulación oral

    Anales de Medicina Interna, Vol. 20, Núm. 7, pp. 377-384